参考文献/References:
[1] Rubler S,Dlugash J,Yuceoglu YZ,et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis[J]. Am J Cardiol,1972,30(6):595-602.
[2] Nakamura K,Miyoshi T,Yoshida M,et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus[J]. Int J Mol Sci,2022,23(7):3587.
[3] Yan M,Li Y,Luo Q,et al. Mitochondrial damage and activation of the cytosolic DNA sensor cGAS-STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice[J]. Cell Death Discov,2022,8(1):258.
[4] Frangogiannis NG. Cardiac fibrosis[J]. Cardiovasc Res,2021,117(6):1450-1488.
[5] Atici AE,Crother TR,Noval Rivas M. Mitochondrial quality control in health and cardiovascular diseases[J]. Front Cell Dev Biol,2023,11:1290046.
[6] Prandi FR,Evangelista I,Sergi D,et al. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy:molecular abnormalities and phenotypical variants[J]. Heart Fail Rev,2023,28(3):597-606.
[7] Lin J,Duan J,Wang Q,et al. Mitochondrial dynamics and mitophagy in cardiometabolic disease[J]. Front Cardiovasc Med,2022,9:917135.
[8] Jin L,Geng L,Ying L,et al. FGF21-sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity[J]. Circulation,2022,146(20):1537-1557.
[9] Huo S,Wang Q,Shi W,et al. ATF3/SPI1/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury[J]. Int J Mol Sci,2023,24(2):1667.
[10] Ke J,Pan J,Lin H,et al. Diabetic cardiomyopathy:a brief summary on lipid toxicity[J]. ESC Heart Fail,2023,10(2):776-790.
[11] Klionsky DJ,Abeliovich H,Agostinis P,et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes[J]. Autophagy,2008,4(2):151-175.
[12] Lu Y,Li Z,Zhang S,et al. Cellular mitophagy:mechanism,roles in diseases and small molecule pharmacological regulation[J]. Theranostics,2023,13(2):736-766.
[13] Zhang M,Sui W,Xing Y,et al. Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy,apoptosis and fibrosis[J]. Theranostics,2021,11(18):8624-8639.
[14] Wang N,Zhu P,Huang R,et al. PINK1:the guard of mitochondria[J]. Life Sci,2020,259:118247.
[15] Wilhelm LP,Zapata-Mu?oz J,Villarejo-Zori B,et al. BNIP3L/NIX regulates both mitophagy and pexophagy[J]. EMBO J,2022,41(24):e111115.
[16] Nguyen-Dien GT,Kozul KL,Cui Y,et al. FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors[J]. EMBO J,2023,42(13):e112767.
[17] Sun Y,Zhou S,Guo H,et al. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function[J]. Metabolism,2020,102:154002.
[18] Han YC,Tang SQ,Liu YT,et al. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice[J]. Cell Death Dis,2021,12(10):925.
[19] Drake JC,Wilson RJ,Laker RC,et al. Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy[J]. Proc Natl Acad Sci U S A,2021,118(37):e2025932118.
[20] Parmar UM,Jalgaonkar MP,Kansara AJ,et al. Emerging links between FOXOs and diabetic complications[J]. Eur J Pharmacol,2023,960:176089.
[21] Yao J,Wang J,Xu Y,et al. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma[J]. Autophagy,2022,18(8):1879-1897.
[22] Salin Raj P,Nair A,Preetha Rani MR,et al. Ferulic acid attenuates high glucose-induced MAM alterations via PACS2/IP3R2/FUNDC1/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats[J]. Int J Cardiol,2023,372:101-109.
[23] Bi Y,Liu S,Qin X,et al. FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner[J]. J Adv Res,2024,55:45-60.
[24] Chu C,Wang X,Yang C,et al. Neutrophil extracellular traps drive intestinal microvascular endothelial ferroptosis by impairing Fundc1-dependent mitophagy[J]. Redox Biol,2023,67:102906.
[25] Peng H,Fu S,Wang S,et al. Ablation of FUNDC1-dependent mitophagy renders myocardium resistant to paraquat-induced ferroptosis and contractile dysfunction[J]. Biochim Biophys Acta Mol Basis Dis,2022,1868(9):166448.
[26] Li FJ,Hu H,Wu L,et al. Ablation of mitophagy receptor FUNDC1 accentuates septic cardiomyopathy through ACSL4-dependent regulation of ferroptosis and mitochondrial integrity[J]. Free Radic Biol Med,2024,225:75-86.
[27] Pei Z,Liu Y,Liu S,et al. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis[J]. Metabolism,2021,122:154840.
[28] Zahid MA,Abdelsalam SS,Raiq H,et al. Sestrin2 as a protective shield against cardiovascular disease[J]. Int J Mol Sci,2023,24(5):4880.
[29] Song S,Shi C,Bian Y,et al. Sestrin2 remedies podocyte injury via orchestrating TSP-1/TGF-β1/Smad3 axis in diabetic kidney disease[J]. Cell Death Dis,2022,13(7):663.
[30] Watany MM,El-Horany HE,Elhosary MM,et al. Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease[J]. Mol Med,2022,28(1):147.
[31] Ding X,Zhao H,Qiao C. Icariin protects podocytes from NLRP3 activation by Sesn2-induced mitophagy through the Keap1-Nrf2/HO-1 axis in diabetic nephropathy[J]. Phytomedicine,2022,99:154005.
[32] Xiao T,Zhao H,Wang Y,et al. Shionone inhibits glomerular fibirosis by suppressing NLRP3 related inflammasome though SESN2-NRF2/ HO-1 pathway[J]. Diabetes Metab J,2025,49(1):34-48.
[33] Li S,Liu M,Chen J,et al. L-carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1-Parkin-dependent mitophagy through the CPT1a-PHB2-PARL pathways[J]. Acta Physiol (Oxf),2023,238(3):e13975.
[34] Li Y,Chen H,Xie X,et al. PINK1-mediated mitophagy promotes oxidative phosphorylation and redox homeostasis to induce drug-tolerant persister cancer cells[J]. Cancer Res,2023,83(3):398-413.
[35] Yin K,Lee J,Liu Z,et al. Mitophagy protein PINK1 suppresses colon tumor growth by metabolic reprogramming via p53 activation and reducing acetyl-CoA production[J]. Cell Death Differ,2021,28(8):2421-2435.
[36] Boshchenko AA,Maslov LN,Mukhomedzyanov AV,et al. Peptides are cardioprotective drugs of the future:the receptor and signaling mechanisms of the cardioprotective effect of glucagon-like peptide-1 receptor agonists[J]. Int J Mol Sci,2024,25(9):4900.
[37] Wang J,Yang K,Liu C,et al. H3 relaxin ameliorates mitochondrial quality control and apoptosis in cardiomyocytes of type 2 diabetic rats via activation of the AMPK pathway[J]. Int Immunopharmacol,2025,144:113664.
[38] Tan X,Chen YF,Zou SY,et al. ALDH2 attenuates ischemia and reperfusion injury through regulation of mitochondrial fusion and fission by PI3K/AKT/mTOR pathway in diabetic cardiomyopathy[J]. Free Radic Biol Med,2023,195:219-230.
[39] Yu LM,Dong X,Xue XD,et al. Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control:Role of SIRT6[J]. J Pineal Res,2021,70(1):e12698.
[40] Arab HH,Al-Shorbagy MY,Saad MA. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats:targeting AMPK/mTOR,HMGB1/RAGE and Nrf2/HO-1 pathways[J]. Chem Biol Interact,2021,335:109368.
[41] Chen Z,Li S,Liu M,et al. Nicorandil alleviates cardiac microvascular ferroptosis in diabetic cardiomyopathy:role of the mitochondria-localized AMPK-Parkin-ACSL4 signaling pathway[J]. Pharmacol Res,2024,200:107057.
相似文献/References:
[1]王静娜,侯瑞田,史亦男,等.糖尿病心肌病发病机制及病理改变研究进展[J].心血管病学进展,2016,(4):412.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.022]
WANG Jingna,HOU Ruitian,SHI Yinan,et al.Research Progress on Pathogenesis and Pathological Changes
of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2016,(8):412.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.022]
[2]杨沫,姜文锡.线粒体功能异常在糖尿病心肌病发病机制中的作用[J].心血管病学进展,2015,(6):731.[doi:10.3969/j.issn.1004-3934.2015.06.019]
YANG Mo,JIANG Wenxi.Mitochondrial Dysfunction of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(8):731.[doi:10.3969/j.issn.1004-3934.2015.06.019]
[3]朱月红,戴启明.糖尿病心肌病的内质网病变机制及干预[J].心血管病学进展,2015,(6):738.[doi:10.3969/j.issn.1004-3934.2015.06.021]
ZHU Yuehong,DAI Qiming.Advance of Mechanism and Intervention of Endoplasmic Reticulum in
Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2015,(8):738.[doi:10.3969/j.issn.1004-3934.2015.06.021]
[4]位晨晨,钟明.糖尿病心肌病的发病机制[J].心血管病学进展,2020,(2):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
WEI Chenchen,ZHONG Ming.Pathogenesis of Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(8):135.[doi:10.16806/j.cnki.issn.1004-3934.20.02.009]
[5]付辉,黄鹤.线粒体功能障碍在心血管疾病中的作用[J].心血管病学进展,2020,(3):306.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.022]
FU Hui,HUANG He.Role of Mitochondrial Dysfunction in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(8):306.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.022]
[6]武韧 常贵全 孙凤起 李鸿珠.硫化氢对糖尿病心肌病的保护作用[J].心血管病学进展,2021,(1):52.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
WU Ren,CHANG Guiquan,SUN Fengqi,et al.Protective Effect of Hydrogen Sulfide in Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2021,(8):52.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
[7]宋元秀 崔鸣.线粒体动力学异常与相关心血管疾病[J].心血管病学进展,2021,(2):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
SONG Yuanxiu,CUI Ming.Correlation Between Mitochondrial Dynamics and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2021,(8):162.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.017]
[8]马韵之 李剑 周鹏.糖尿病心肌病血清生物标志物研究进展[J].心血管病学进展,2021,(5):392.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.002]
Serum Biomarkers of Diabetic Cardiomyopathy.[J].Advances in Cardiovascular Diseases,2021,(8):392.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.002]
[9]李开 饶莉.线粒体自噬的分子生物学过程及其在心脏疾病中的作用[J].心血管病学进展,2022,(3):222.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
LI Kai,RAO Li.Molecular Biological Process of Mitophagy and Its Role in Heart Diseases[J].Advances in Cardiovascular Diseases,2022,(8):222.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[10]李艳鹏 马依彤.糖尿病心肌病治疗策略的研究进展[J].心血管病学进展,2022,(9):795.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.007]
LI Yanpeng,MA Yitong.Treatment Strategies for Diabetic Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(8):795.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.007]